Sponsors
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Blog
Where our team of editors discuss what they think about the current NGP US Issues.
Editor NGP US
Sizing up the future
What role will individually tailored therapies play in the pharmaceutical industry’s new business models?01 Oct 2009
Focus Area: Clinical Trials
A Whole New Class of Human Therapeutics
The pharmaceutical industry is more starved than ever for innovation – the most important strategy that every single pharmaceutical company relies on to grow and build their business.
Learn and Confirm
A new pharmaceutical environment has arrived – one that requires pharmaceutical companies to make the clinical development process more productive and efficient.
Company Focus: SpinX Technologies
Bart Van de Vyver, Ph.D, CEO, Piero Zucchelli, Ph.D., CSO and Michael Biros, Head of Sales, North America, provide insight to the industry’s excitement over SpinX Technologies’ unique approach to nanoliter-scale assay automation.
UBC Continues Rapid Growth in Specialized Services
Author: Mark P. Clein, President and Co-Founder,
United BioSource Corporation
How The Art of Project Management® improved the performance of pharmaceutical clinical trials in a Major Global Pharmaceutical Company
Thomas G. Johns, Ph.D., PE, PMP, MAPM, Senior Partner
Source: www.ngpharma.com© 2010 GDS Publishing Ltd. All rights reserved.